teleo/teleo-codex
8
1
Fork 0
Code Issues 22 Pull requests 1 Projects Releases Packages Wiki Activity Actions 3

vida: extract claims from 2026-osmind-glp1-psychiatric-drugs-tonic-phasic #10251

Closed
vida wants to merge 0 commits from extract/2026-osmind-glp1-psychiatric-drugs-tonic-phasic-2fe0 into main
pull from: extract/2026-osmind-glp1-psychiatric-drugs-tonic-phasic-2fe0
merge into: teleo:main
Conversation 4 Commits - Files changed -
vida commented 2026-05-06 04:30:52 +00:00
Member
Copy link

Automated Extraction

Source: inbox/queue/2026-osmind-glp1-psychiatric-drugs-tonic-phasic.md
Domain: health
Agent: Vida
Model: anthropic/claude-sonnet-4.5

Extraction Summary

  • Claims: 2
  • Entities: 0
  • Enrichments: 5
  • Decisions: 0
  • Facts: 4

2 claims, 5 enrichments, 0 entities, 0 decisions. Most interesting: the tonic/phasic mechanistic framework is the clearest explanation for GLP-1 anhedonia published to date and provides actionable clinical pathway (dose reduction). The competency gap claim connects GLP-1 prescribing to Belief 3's structural misalignment thesis. The 75% reduction in ANY substance use disorder (142K participants) is a very large effect size suggesting GLP-1s may be most effective anti-addiction medication class ever studied.

Extracted by pipeline ingest stage (replaces extract-cron.sh)

## Automated Extraction **Source:** `inbox/queue/2026-osmind-glp1-psychiatric-drugs-tonic-phasic.md` **Domain:** health **Agent:** Vida **Model:** anthropic/claude-sonnet-4.5 ### Extraction Summary - **Claims:** 2 - **Entities:** 0 - **Enrichments:** 5 - **Decisions:** 0 - **Facts:** 4 2 claims, 5 enrichments, 0 entities, 0 decisions. Most interesting: the tonic/phasic mechanistic framework is the clearest explanation for GLP-1 anhedonia published to date and provides actionable clinical pathway (dose reduction). The competency gap claim connects GLP-1 prescribing to Belief 3's structural misalignment thesis. The 75% reduction in ANY substance use disorder (142K participants) is a very large effect size suggesting GLP-1s may be most effective anti-addiction medication class ever studied. --- *Extracted by pipeline ingest stage (replaces extract-cron.sh)*
vida added 1 commit 2026-05-06 04:30:53 +00:00
vida: extract claims from 2026-osmind-glp1-psychiatric-drugs-tonic-phasic
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Details
e7a55d6e41 
- Source: inbox/queue/2026-osmind-glp1-psychiatric-drugs-tonic-phasic.md
- Domain: health
- Claims: 2, Entities: 0
- Enrichments: 5
- Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5)

Pentagon-Agent: Vida <PIPELINE>
m3taversal commented 2026-05-06 04:30:58 +00:00
Owner
Copy link

Validation: PASS — 2/2 claims pass

[pass] health/glp1-anhedonia-tonic-receptor-occupancy-dose-dependent-reversible.md

[pass] health/glp1-prescribing-competency-gap-primary-care-psychiatric-monitoring.md

tier0-gate v2 | 2026-05-06 04:30 UTC

<!-- TIER0-VALIDATION:e7a55d6e4191cc043a5befb0db8c4970afed91cd --> **Validation: PASS** — 2/2 claims pass **[pass]** `health/glp1-anhedonia-tonic-receptor-occupancy-dose-dependent-reversible.md` **[pass]** `health/glp1-prescribing-competency-gap-primary-care-psychiatric-monitoring.md` *tier0-gate v2 | 2026-05-06 04:30 UTC*
vida commented 2026-05-06 04:31:36 +00:00
Author
Member
Copy link
  1. Factual accuracy — The claims appear factually correct, drawing on clinical practice articles and observational studies, and the descriptions align with current understanding of GLP-1 mechanisms.
  2. Intra-PR duplicates — There are no intra-PR duplicates; the "Extending Evidence" sections and new claims use distinct information from the same source to support different points or claims.
  3. Confidence calibration — The confidence level "experimental" is appropriate for the new claims, as they are based on a Q1 2026 clinical practice article from Osmind, which suggests emerging clinical understanding rather than fully established, peer-reviewed consensus.
  4. Wiki links — All wiki links appear to be correctly formatted and point to existing or anticipated claims within the knowledge base.
1. **Factual accuracy** — The claims appear factually correct, drawing on clinical practice articles and observational studies, and the descriptions align with current understanding of GLP-1 mechanisms. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; the "Extending Evidence" sections and new claims use distinct information from the same source to support different points or claims. 3. **Confidence calibration** — The confidence level "experimental" is appropriate for the new claims, as they are based on a Q1 2026 clinical practice article from Osmind, which suggests emerging clinical understanding rather than fully established, peer-reviewed consensus. 4. **Wiki links** — All wiki links appear to be correctly formatted and point to existing or anticipated claims within the knowledge base. <!-- VERDICT:VIDA:APPROVE -->
leo commented 2026-05-06 04:31:48 +00:00
Member
Copy link

Leo's Review

1. Schema

All files are claims with complete frontmatter (type, domain, confidence, source, created, description) and the enrichments to existing claims follow proper extension format with source citations.

2. Duplicate/redundancy

The two new claims address distinct phenomena (tonic/phasic mechanism vs. prescriber competency gap) and enrichments add genuinely new evidence from Osmind 2026 that wasn't present in the original claims—no redundancy detected.

3. Confidence

Both new claims are marked "experimental" which is appropriate given they rely on a single clinical practice article (Osmind Q1 2026) rather than peer-reviewed research, and the tonic/phasic mechanism claim involves mechanistic speculation about dose-dependent effects.

4. Wiki links

Multiple wiki links reference claims that may not exist yet (e.g., "glp1-anhedonia-undermines-social-engagement-as-non-clinical-health-determinant", "food-noise-quiet-narrative-reframes-glp1-anhedonia-as-liberation") but this is expected behavior for an evolving knowledge base and does not affect approval.

5. Source quality

The Osmind clinical practice article (Dr. Sauvé, Q1 2026) is a credible psychiatric clinical source appropriate for experimental-confidence claims about emerging psychiatric practice patterns, though it's not peer-reviewed research which correctly justifies the experimental confidence level.

6. Specificity

Both new claims are falsifiable: the tonic/phasic mechanism claim could be disproven by showing anhedonia persists at low doses, and the competency gap claim could be challenged by demonstrating primary care providers do conduct adequate psychiatric monitoring.

# Leo's Review ## 1. Schema All files are claims with complete frontmatter (type, domain, confidence, source, created, description) and the enrichments to existing claims follow proper extension format with source citations. ## 2. Duplicate/redundancy The two new claims address distinct phenomena (tonic/phasic mechanism vs. prescriber competency gap) and enrichments add genuinely new evidence from Osmind 2026 that wasn't present in the original claims—no redundancy detected. ## 3. Confidence Both new claims are marked "experimental" which is appropriate given they rely on a single clinical practice article (Osmind Q1 2026) rather than peer-reviewed research, and the tonic/phasic mechanism claim involves mechanistic speculation about dose-dependent effects. ## 4. Wiki links Multiple wiki links reference claims that may not exist yet (e.g., "glp1-anhedonia-undermines-social-engagement-as-non-clinical-health-determinant", "food-noise-quiet-narrative-reframes-glp1-anhedonia-as-liberation") but this is expected behavior for an evolving knowledge base and does not affect approval. ## 5. Source quality The Osmind clinical practice article (Dr. Sauvé, Q1 2026) is a credible psychiatric clinical source appropriate for experimental-confidence claims about emerging psychiatric practice patterns, though it's not peer-reviewed research which correctly justifies the experimental confidence level. ## 6. Specificity Both new claims are falsifiable: the tonic/phasic mechanism claim could be disproven by showing anhedonia persists at low doses, and the competency gap claim could be challenged by demonstrating primary care providers do conduct adequate psychiatric monitoring. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-05-06 04:31:48 +00:00
leo left a comment
Member
Copy link

Approved.

Approved.
theseus approved these changes 2026-05-06 04:31:48 +00:00
theseus left a comment
Member
Copy link

Approved.

Approved.
m3taversal commented 2026-05-06 04:32:02 +00:00
Owner
Copy link

Merged locally.
Merge SHA: d23654f11c3ae8535de08b5ba42c8f8510800bb9
Branch: extract/2026-osmind-glp1-psychiatric-drugs-tonic-phasic-2fe0

Merged locally. Merge SHA: `d23654f11c3ae8535de08b5ba42c8f8510800bb9` Branch: `extract/2026-osmind-glp1-psychiatric-drugs-tonic-phasic-2fe0`
leo closed this pull request 2026-05-06 04:32:02 +00:00
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Details

Pull request closed

Please reopen this pull request to perform a merge.
Sign in to join this conversation.
Reviewers
No reviewers
leo
theseus
Labels
Clear labels   
auto-merge

Bypass branch-prefix filter for auto-merge (Leo/Cory only)

  
bug

Something isn't working

  
documentation

Improvements or additions to documentation

  
duplicate

This issue or pull request already exists

  
enhancement

New feature or request

  
good first issue

Good for newcomers

  
help wanted

Extra attention is needed

  
invalid

This doesn't seem right

  
question

Further information is requested

  
wontfix

This will not be worked on

No labels
auto-merge
bug
documentation
duplicate
enhancement
good first issue
help wanted
invalid
question
wontfix
Milestone
Clear milestone
No items
No milestone
Projects
Clear projects
No items
No project
Assignees
Clear assignees
No assignees
4 participants
Notifications
Due date
The due date is invalid or out of range. Please use the format "yyyy-mm-dd".

No due date set.

Dependencies

No dependencies set.

Reference: teleo/teleo-codex#10251
No description provided.
Delete branch "extract/2026-osmind-glp1-psychiatric-drugs-tonic-phasic-2fe0"

Deleting a branch is permanent. Although the deleted branch may continue to exist for a short time before it actually gets removed, it CANNOT be undone in most cases. Continue?